Related references
Note: Only part of the references are listed.A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
Albert Moghrabi et al.
BLOOD (2007)
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial
Valentino Conter et al.
LANCET (2007)
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95
Andre Schrauder et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate
Brenda J. Spiegler et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study
A Balduzzi et al.
LANCET (2005)
Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial
CD Mitchell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia
SE Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors
PK Duffner
NEUROLOGIST (2004)
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
BC Bostrom et al.
BLOOD (2003)
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia:: Significance of low leukocyte counts with blasts or traumatic lumbar puncture
B Bürger et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro
M Akutsu et al.
LEUKEMIA (2002)
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II
M Aricò et al.
BLOOD (2002)
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients:: results of DCLSG protocol ALL-8 (1991-1996)
WA Kamps et al.
LEUKEMIA (2002)
CNS late-effects after ALL therapy in childhood. Part III: Neuropsychological performance in long-term survivors of childhood ALL: Impairments of concentration, attention, and memory
T Langer et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
BJ Lange et al.
BLOOD (2002)
Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber ALL consortium protocol 87-01
JM LeClerc et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia:: a CLCG-EORTC report
E Vilmer et al.
LEUKEMIA (2000)
Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995
M Tsuchida et al.
LEUKEMIA (2000)
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)
LB Silverman et al.
LEUKEMIA (2000)
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995
M Schrappe et al.
LEUKEMIA (2000)
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital
CH Pui et al.
LEUKEMIA (2000)
Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994
KW Maloney et al.
LEUKEMIA (2000)
Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991
WA Kamps et al.
LEUKEMIA (2000)
Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92
DO Harms et al.
LEUKEMIA (2000)
Improving outcome through two decades in childhood ALL in the Nordic countries:: the impact of high-dose methotrexate in the reduction of CNS irradiation
G Gustafsson et al.
LEUKEMIA (2000)
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995
PS Gaynon et al.
LEUKEMIA (2000)
Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
OB Eden et al.
LEUKEMIA (2000)
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995
V Conter et al.
LEUKEMIA (2000)
Share Paper
